Dr Bill Nelson and Dr Bert Vogelstein discuss the development of tools for the early detection of cancers, which will lead to better treatments with fewer long-term consequences for patients.

Dr Bill Nelson speaks with Dr Kala Visvanathan about her research assessing breast cancer risk, why many people are developing cancers earlier in life, and the tools she is developing to find cancer sooner, when it can be treated more effectively.

Dr Bill Nelson and Dr Chi Dang discuss the impact of circadian rhythms on our metabolism and how researchers are working to utilize this knowledge to improve cancer treatment.

Dr Bill Nelson talks to Dr Andrew Ewald, a cell biologist, about his research into how cancer cells migrate throughout the body and the importance of federal funding to continue building on decades of successful research efforts.

Dr Bill Nelson speaks with Dr Elizabeth Jaffee about her research in cancer vaccines, immunotherapy, and the importance of federal funding in continuing to achieve breakthroughs in cancer treatment.

Dr Bill Nelson talks with Dr Denis Wirtz about his research using CODA, an artificial intelligence platform, to identify and analyze pre-cancerous lesions previously undetected in the pancreas and along the fallopian tubes.

Dr Bill Nelson talks with Dr Ashani Weeraratna about her work in melanoma research, the progress that has been made in treating patients with melanoma, and the importance of federal research funding in finding advancements in treatment for this disease.

Dr Bill Nelson talks to Dr Drew Pardoll about the field of cancer immunology. They explain how cancer cells use 'checkpoints' to turn off immune response and how research efforts at Johns Hopkins to block these checkpoints and re-engage the immune system continue to benefit patients.